Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Inc (NY: ELAN )

10.50 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Elanco Animal Health Inc

< Previous 1 2 3 4 Next >
Transocean, Elanco Animal And This Major Tech Stock: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Alphabet Inc. (NASDAQ: GOOGL) as 
Via Benzinga
Elanco Animal Health (ELAN) Q2 2023 Earnings Call Transcript
ELAN earnings call for the period ending June 30, 2023. 
Via The Motley Fool
PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories
Benzinga 
Via Benzinga
Elanco Animal Health, Sovos Brands, Veritiv, Graham And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Earnings Outlook For Elanco Animal Health
Via Benzinga
Expert Ratings for Elanco Animal Health
Via Benzinga
Earnings Preview: Elanco Animal Health
Via Benzinga
What 4 Analyst Ratings Have To Say About Elanco Animal Health
Via Benzinga
Elanco Animal Health Stock Gains On Strong Q2 Earnings, Upbeat Annual Guidance
Elanco Animal Health Inc (NYSE: ELAN) has reported a Q2 FY23 revenue of $1.06 billion. 
Via Benzinga
Why Investors Were Barking Loudly About Elanco Animal Health Stock Today
One of the company's longest-lasting products will stay on the market, it said. 
Via The Motley Fool
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement. 
Via Benzinga
Elanco Animal Health's Return On Capital Employed Overview
Via Benzinga
Where Elanco Animal Health Stands With Analysts
Elanco Animal Health (NYSE:ELAN) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Expert Ratings for Elanco Animal Health
Within the last quarter, Elanco Animal Health (NYSE:ELAN) has observed the following analyst ratings: 
Via Benzinga
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
7 Under-$10 Sleeper Stocks to Buy Before Investors Wake Up
Investors may want to consider these top seven sleeper stocks under $10 a share, as we head into the second half of 2023. 
Via InvestorPlace
2 Unstoppable Growth Stocks Wall Street Thinks Can Soar by at Least 70%
According to analysts, these could be great growth stocks to buy right now. 
Via The Motley Fool
Elanco Animal Health (ELAN) Q1 2023 Earnings Call Transcript
ELAN earnings call for the period ending March 31, 2023. 
Via The Motley Fool
US Stock Futures Slide On Inflation Fears: Analyst Sees Risk-Off Mood As Debt-Ceiling Crisis Looms
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
Via Benzinga
Elanco Animal Health (ELAN) Q4 2022 Earnings Call Transcript
ELAN earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023. 
Via Benzinga
Elanco Animal Health Clocks 11% Lower Q4 Sales, FY22 Profit Guidance Below Consensus
Via Benzinga
Nasdaq, S&P 500 Futures Slump As Traders Weigh-In Retail Earnings, Uncertain Economic Backdrop
Trading in the index futures suggests stocks may open Monday’s session on a markedly negative note, although retail earnings scheduled for the day and a couple of readings on the manufacturing and the... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Coupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Nasdaq, S&P 500 Futures Nervously Flit Around Ahead Of November Payrolls Data: Will Numbers Support Market Expectations For Slower Rate Hikes?
US stocks are on track for a nervous start on Friday as traders look ahead to the November non-farm payrolls report for trading cues. With the Federal Reserve signaling its intention to potentially... 
Via Benzinga
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at... 
Via Benzinga
What 6 Analyst Ratings Have To Say About Elanco Animal Health
Over the past 3 months, 6 analysts have published their opinion on Elanco Animal Health (NYSE:ELAN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
Elanco Animal Health Inc. (ELAN) Q3 2022 Earnings Call Transcript
ELAN earnings call for the period ending September 30, 2022. 
Via The Motley Fool
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.